This segment encompasses the operation of a vast network of pharmacy stores across 21 provinces in China. LBX Pharmacy Chain focuses on providing a wide array of pharmaceutical products, over-the-counter medications, and healthcare-related items directly to consumers. The company leverages its extensive retail footprint to ensure accessibility and convenience for patients. R&D activities in this segment may include the development of new pharmacy services, such as medication therapy management and chronic disease management programs. Technologies employed include advanced inventory management systems, point-of-sale systems, and digital health platforms to enhance customer experience and operational efficiency. Patient impact is significant, as the company provides essential medications and healthcare products to a large population. Market positioning is strong, with a leading presence in the Chinese pharmaceutical retail market. Future opportunities include expanding its store network, enhancing its online presence, and offering value-added services. Regulatory aspects involve compliance with Chinese pharmaceutical regulations and ensuring the quality and safety of all products. Partnerships with local clinics and healthcare providers are key to expanding its service offerings.

This segment focuses on the distribution of pharmaceutical products to other pharmacies, hospitals, and healthcare providers. LBX Pharmacy Chain leverages its established supply chain and distribution network to ensure the timely and efficient delivery of medications across its operational regions. R&D activities in this segment may involve optimizing logistics and supply chain management to reduce costs and improve efficiency. Technologies used include advanced warehousing systems, transportation management systems, and data analytics to track inventory and optimize distribution routes. The therapeutic areas covered are broad, encompassing a wide range of medications and healthcare products. Patient impact is realized through ensuring the availability of essential medicines to healthcare providers. Market positioning is competitive, with the company aiming to be a reliable and efficient distributor in the Chinese pharmaceutical market. Future opportunities include expanding its distribution network, entering new markets, and offering value-added services such as cold chain logistics. Regulatory aspects involve compliance with Chinese pharmaceutical distribution regulations and ensuring the integrity of the supply chain. Partnerships with pharmaceutical manufacturers and other distributors are crucial for maintaining a diverse product portfolio and ensuring competitive pricing.